(R) -BDP9066
(R) -BDP9066 is an isomer of BDP9066 and has lower activity compared to BDP9066. BDP9066 is a potent inhibitor of myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) . (R) -BDP9066 is derived from patent WO2019034890A1 (E118) [1].
Product Specifications
CAS Number
[2284549-25-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Cdc42-binding kinase
Type
Reference compound
Related Pathways
Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/r-bdp9066.html
Purity
98.49
Solubility
DMSO : 20 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N(CCC1)(C2=C3C(NC=C3C4=NC=NC=C4)=NC=C2)C[C@]51CCCCN5
Molecular Formula
C20H24N6
Molecular Weight
348.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer. Patent WO2019034890A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Dictyostelium discoideum ER lumen protein retaining receptor (kdelr), partial
RALBP1 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI11C6]
